AMPLIPHI BIOSCIENCES
AmpliPhi Biosciences is a biopharmaceutical company focused on the development of an internally generated pipeline of naturally occurring viruses called bacteriophage (phage) for the treatment of bacterial infection. Phage-based therapy provides a unique and proven approach to treating a wide variety of bacterial infections and in particular, drug-resistant strains of bacteria that are commonly found in the hospital setting. We have built a drug development and manufacturing platform designed ... to allow rapid development and production of multiple phage-based therapies. Our plan and success relies on our ability to identify and develop selected phage to eradicate targeted bacterial infections across a wide range of bacterial disease. Initially our phage discovery and development platform will focus efforts in acute and chronic lung, sinus and gastrointestinal (GI) infections. AmpliPhi maintains operations in Richmond, Virginia in the United States, in Colworth Science Park, near London in the United Kingdom, and outside Sydney, NSW, Australia.
AMPLIPHI BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1989-01-01
Address:
Richmond, Virginia, United States
Country:
United States
Website Url:
http://www.ampliphibio.com
Total Employee:
11+
Status:
Active
Contact:
+118048272524
Total Funding:
43.99 M USD
Technology used in webpage:
Domain Not Resolving SPF Font Awesome IPv6 Microsoft Exchange Online Google Office 365 Mail Google Cloud Microsoft Azure DNS YouTube
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Board_member
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-04 | C3J Therapeutics | C3J Therapeutics acquired by AmpliPhi Biosciences | N/A |
| 2016-01-08 | Novolytics | Novolytics acquired by AmpliPhi Biosciences | N/A |
| 2011-01-01 | Biocontrol | Biocontrol acquired by AmpliPhi Biosciences | N/A |
Investors List
ROTH Capital Partners
ROTH Capital Partners investment in Post-IPO Equity - AmpliPhi Biosciences
RA Capital Management
RA Capital Management investment in Post-IPO Equity - AmpliPhi Biosciences
BioScience Managers Limited
BioScience Managers Limited investment in Post-IPO Equity - AmpliPhi Biosciences
Third Security
Third Security investment in Post-IPO Equity - AmpliPhi Biosciences
Venrock
Venrock investment in Venture Round - AmpliPhi Biosciences
Official Site Inspections
http://www.ampliphibio.com
- Host name: 180.114.199.104.bc.googleusercontent.com
- IP address: 104.199.114.180
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "AmpliPhi Biosciences"
AmpliPhi Company Profile | Management and Employees List
Www.ampliphibio.com . AmpliPhi Profile and History. AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant …See details»
AmpliPhi Biosciences Corp. - Drug pipelines, Patents, Clinical trials ...
Ampliphibio.com. Private Company | 1989 | Virginia, United States | 10-50 | NYSE: APHB | ampliphibio.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. …See details»
AmpliPhi - Overview, News & Similar companies | ZoomInfo.com
Nov 10, 2021 AmpliPhi contact info: Phone number: (858) 800-4869 Website: www.ampliphibio.com What does AmpliPhi do? AmpliPhi Biosciences Corporation, a …See details»
AmpliPhi Biosciences Company Overview, Contact Details
Mar 11, 2015 AmpliPhi Biosciences. Biotechnology Research California, United States 11-50 Employees. Seasoned drug development teams from AmpliPhi Biosciences Corporation and …See details»
AmpliPhi Biosciences - Craft
San Diego, CA HQ. United States. 3579 Valley Centre Dr # 300. Richmond, VA. United States. Biotech Center, 800 E Leigh St. Brookvale, New South Wales. AustraliaSee details»
AmpliPhi Biosciences Corporation - Seattle, USA - bionity.com
Jun 8, 2015 AmpliPhi BioSciences Corporation, created in 2011 through the merger of Biocontrol Limited with Targeted Genetics Inc., is a biotechnology company dedicated to the …See details»
AmpliPhi Biosciences Information - RocketReach
Seasoned drug development teams from AmpliPhi Biosciences Corporation and C3J Therapeutics have joined together to form Armata Pharmaceuticals (NYSE American: ARMP) …See details»
Ampliphi Biosciences Corp. Company Profile | StatInvestor
Ampliphi Biosciences Company Profile. Learn more about who Ampliphi Biosciences is. Get financial information, who is the owner of Ampliphi Biosciences and key facts about Ampliphi …See details»
AmpliPhi Biosciences - Products, Competitors, Financials, …
Headquarters Location. 4503 Glencoe Avenue . Marina del Rey, California, 90292, United States. 310-665-2928See details»
AmpliPhi Biosciences - VentureRadar
Website: http://www.ampliphibio.com/ Biotechnology company dedicated to the development of innovative antibacterial solutions to improve human health through the ...See details»
AmpliPhi Biosciences Corp (Form: 8-K, Received: 01/14/2019 …
Jan 14, 2019 organization) (IRS Employer Identification No.) 3579 Valley Centre Drive, Suite 100 San Diego, California 92130 ... the proxy statement will be available free of charge on …See details»
AmpliPhi Biosciences - PitchBook
AmpliPhi Biosciences General Information Description. Developer of bacteriophage technology intended to control human diseases. The company is focused on improving human health …See details»
AmpliPhi Biosciences Corp Overview - Salary.com
Discover essential details about AmpliPhi Biosciences Corp, including address, contact, and journey of our company's evolution.See details»
AmpliPhi Biosciences and C3J Therapeutics Agree to Merge
Jan 4, 2019 Once filed, the proxy statement will be available free of charge on AmpliPhi’s website at www.ampliphibio.com or by contacting AmpliPhi’s Investor Relations by email at …See details»
AmpliPhi Biosciences Provides Corporate and Strategic Update
Dec 14, 2017 SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of …See details»
AB-PA01 - Drug Targets, Indications, Patents - Synapse
AB-PA01: a Bacterial RNA modulators, DNA modulators Drug, Initially developed by AmpliPhi Biosciences Corp., Now, its global highest R&D status is Phase 1, Mechanism: Bacterial RNA …See details»
About Us - AmplifyBio
AmplifyBio spun out from Battelle in 2021 as a preclinical CRO with decades of experience designing and delivering in vivo safety, efficacy, and toxicology studies for the preparation of …See details»
AmplifyBio - Advanced Therapy CDMO
Jul 30, 2024 AmplifyBio is a concept to commercial CRO dedicated to providing expert services for drug discovery, characterization, optimization, in vitro and in vivo safety studies, and …See details»
Product - Ampliphi
Ampliphi is an intelligent plastic action platform that helps consumer brands and retailers accelerate the transition to a circular economy. By harnessing the power of data, we enable …See details»